TransAct Technologies Inc. Reports Preliminary Q3 Results; CFO Severance Agreement

What Happened

• TransAct Technologies Inc. filed an 8-K on August 11, 2026 furnishing a press release with preliminary financial results for the three- and six-month periods ended June 30, 2026.
• The company also disclosed that on August 10, 2026 it entered into a severance agreement with its Chief Financial Officer, Troy W. Ingianni. The agreement sets out severance pay and benefits if Mr. Ingianni is terminated without “Cause” or following a qualifying Change in Control.

Key Details

• Press release: Exhibit 99.1 filed August 11, 2026, announces preliminary quarterly results for the three and six months ended June 30, 2026.
• Standard termination (no Change in Control): if terminated without Cause, CFO receives 50% of base salary paid over 6 months; 50% of annual target bonus pro‑rated for the year to date, paid over 6 months; and six months’ company contribution toward medical/dental (subject to plan rules).
• Change-in-Control severance: if a qualifying Change in Control occurs and Mr. Ingianni is terminated without Cause (or resigns for specified reasons within 12 months), he receives 12 months’ base salary and 12 months’ target bonus paid over one year, one year of medical/dental contributions, and immediate vesting of outstanding equity awards. He may elect a lump‑sum payment for salary and bonus (10 days’ notice).
• Receipt of severance is conditioned on a general release of claims; the agreement includes six‑month non‑compete and non‑solicit covenants plus confidentiality obligations. “Cause” and “Change in Control” are defined in the agreement.

Why It Matters

• The 8-K provides investors with preliminary quarterly results (earnings/quarterly results) that may affect the company’s near‑term stock performance once final results are released.
• The severance agreement creates potential cash and equity‑related obligations if the CFO is terminated or a Change in Control occurs—notably full salary and bonus payments and accelerated equity vesting in a sale or merger scenario.
• The release and restrictive covenants are standard protections for the company; investors should note the one‑year acceleration and vesting provisions that could increase costs in a merger or acquisition.